Thanks. To be honest only out of interest sake. Was invested in this some time ago and wanted to know how they were doing and why not more progress. Blood based colon cancer testing that is just part of annual marker tests would be an excellent outcome.
VolitionRX. CEO is an Aussie. More touched base with them in the early days when they were a named competitor to RHY but have stay watching their pivot to see how they go. Cash burn high and they are trying to do a lot of different things at once. INterested to see if this PET detection tech can be profitable.
RHY Price at posting:
59.0¢ Sentiment: None Disclosure: Not Held
